rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-5-22
|
pubmed:abstractText |
Beginning 1998, a working group of specialists convened by the guidelines department (Standards, Options and Recommendations: SOR) of the National French Federation of Comprehensive Cancer Centres (FNCLCC) published then regularly updated Recommendations relative to the use of ESA in anaemic patients with cancer. This article presents a short version of the Recommendations updated in 2007.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1769-6917
|
pubmed:author |
pubmed-author:CasadevallNicoleN,
pubmed-author:ChastagnerPascalP,
pubmed-author:Fédération Française de Cancérologie,
pubmed-author:Fédération Hospitalière de France,
pubmed-author:Fédération Nationale de Cancérologiedes Centres Hospitaliers Regionaux...,
pubmed-author:Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC),
pubmed-author:Institut National du Cancer,
pubmed-author:Kassab-ChahmiDianaD,
pubmed-author:Ligue contre le Cancer pour la Vie,
pubmed-author:MarchalChristianC,
pubmed-author:Marec-BérardPerrineP,
pubmed-author:MissetJean-LouisJL,
pubmed-author:Ray-CoquardIsabelleI,
pubmed-author:Standards, Options et Recommandations (SOR),
pubmed-author:Union Nationale Hospitalière Privée de Cancérologie (UNHPC)
|
pubmed:issnType |
Electronic
|
pubmed:volume |
95
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
433-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)].
|
pubmed:affiliation |
Centre Léon Bérard, Lyon.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review,
Research Support, Non-U.S. Gov't,
Practice Guideline
|